Galectin-3 for indeterminate thyroid cytology

The Lancet Oncology

Volumn 9, Issue 6, 2008, Pages 508-510

  Al Ghuzlan, Abir ^a   Caillou, Bernard ^a   Schlumberger, Martin ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; GALECTIN 3; PROTEOME; THYROID PEROXIDASE; TRANSCRIPTOME;

ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FALSE NEGATIVE RESULT; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IODINE DEFICIENCY; LETTER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; SUBTOTAL THYROIDECTOMY; THYROID ADENOMA; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; THYROIDECTOMY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

BIOPSY, FINE-NEEDLE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; UNNECESSARY PROCEDURES;

EID: 44249098733     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70137-2     Document Type: Letter

References (9)

1. Cooper D., Doherty G., Haugen B., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 1-33
2. Pacini F., Schlumberger M., Dralle H., et al. European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium. Eur J Endocrinol 154 (2006) 787-803
3. Herrmann M., LiVolsi V., Pasha T., et al. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 126 (2002) 710-713
4. Bartolazzi A., and Bussolati G. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 48 (2006) 212-213
5. Rosai J., Carcangiu M., and De Lellis R. Atlas of tumor pathology: tumors of the thyroid gland, third series, fascicle 5 (1992), Armed Force Institute of Pathology, Washington DC 1-343
6. Bartolazzi A., Orlandi F., Saggiorato E., et al. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 9 (2008) 543-549
7. Papotti M., Rodriguez J., De Pompa R., Bartolazzi A., and Rosai J. Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol 18 (2005) 541-546
8. Durand S., Ferraro-Peyret C., Selmi-Ruby A., et al. Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer. J Clin Endocrinol Metab 93 (2008) 1195-1202
9. Borget I., Vielh P., Leboulleux S., Allyn M., Iacobelli S., Schlumberger M., and de Pouvourville G. Assessment of the cost of fine-needle aspiration cytology as a diagnostic tool in patients with thyroid nodules. Am J Clin Pathol 129 (2008) 763-771